Trendlines : Waston Medical and Trendlines Collaborate for Chinese/Israeli Medical Device Innovation

China-based Waston Medical, one of the top players in China's medical device industry, The China-Israel Changzhou Innovation Park, a binational governmental initiative that provides a unique platform for Israeli industrial companies seeking to enter the Chinese market, and Israel-headquartered Trendlines Innovation Labs, the innovation and R&D arm of The Trendlines Group, announced the signing of a collaborative technology innovation and development agreement in the field of intracorporeal anastomosis.

Changzhou Waston Medical Appliance Co., Ltd. was established in 2002 and is located in Wujin High-tech Industrial Development Zone, Jiangsu Province. It covers an area of 100,000 square meters. It has standard workshops of 50,000 square meters, purification workshops of 8,000 square meters, and R&D workshops of 3,000 square meters. Testing equipment; production, R&D, and management personnel who have obtained professional technical titles account for more than 40% of the total.

Relying on the technical support and close cooperation of Peking Union Medical College Hospital, Beijing Military Region General Hospital, Southern Medical University, Soochow University, Changzhou Science and Education City and other institutions, there are 35 invention patents and 98 utility model patents. The company has five categories of products including orthopedic implants, surgical staplers, cardiothoracic surgery implants, surgical instruments and medical three-dimensional printers.

Trendlines Innovation Labs is an innovation partner, inventing and investing with medical device companies around the world. Trendlines Innovation Labs brings a wealth of expertise in invention and development of breakthrough medical products with a focus on innovation. Trendlines Innovation Labs' strength is its ability to invent new solutions and products with speed and focus to meet critical unmet needs and improve the human condition.

The collaboration agreement builds on the strengths of each party by joining forces around technology innovation and development in the field of intracorporeal anastomosis, with a focus on bringing new solutions to the healthcare industry in China and beyond.

Nir Goldenberg, CEO of Trendlines Innovation Labs, added,

Our collaboration with Waston Medical enables us to develop innovative medical products for the Chinese market while leveraging on Waston's in-depth knowledge of market needs, our agile development capabilities, and our close long-term partnership with CIP which provides further support for entering the Chinese market.